Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Patrys Ltd
ASX:PAB

Watchlist Manager
Patrys Ltd Logo
Patrys Ltd
ASX:PAB
Watchlist
Price: 0.037 AUD 2.78% Market Closed
Market Cap: AU$19.2m
Write Note Create Alert Ask AI

Patrys Ltd
Investor Relations

Patrys Ltd. engages in the commercialisation of the group's proprietary technologies to develop natural human antibody-based therapeutic products for the treatment of cancer and the pursuit of non-dilutive funding sources. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2007-07-13. The firm is engaged in developing the treatment of Glioblastoma (GBM) and Triple Negative Breast Cancer (TNBC). The firm has developed two forms of deoxymab 3E10, including PAX-DX1 and PAT-DX3. Its is also using the PAT-DX1 antibody to deliver nanoparticles carrying therapeutic payloads to the inside of cells. The firm is in the process of the first human clinical trial of PAT-DX1. Its two product candidates, PAT-DX2 and PAT-DX1-NP are under preclinical stage.

Show more
Loading
PAB
S&P/ASX 300
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. James A. Campbell B.Sc., MBA, Ph.D.
MD, CEO & Executive Director
No Bio Available
Dr. Rebecca Tunstall
Vice President of Corporate Development
No Bio Available
Mr. Stefan Ross
Company Secretary
No Bio Available
Ms. Valentina Dubljevic BSc, GAICD, MBB
Vice President of Research & Development
No Bio Available

Contacts

Address
VICTORIA
South Melbourne
C:/ Leydin Freyer, Australia, L 4 100 Albert Rd
Contacts
+61396703273.0
www.patrys.com
sparklesyt

See Also

Summary
PAB intrinsic value, competitors valuation, and company profile.
DCF Valuation
PAB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PAB stock valuation using valuation multiples.
Wall Street Estimates
PAB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PAB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 314,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.